Same blood sugar number, different cause
A blood sugar reading can’t tell you why your pancreas is struggling, only that it is. Type 2 diabetes and LADA can look identical on a first glucose or A1C test. The difference is underneath: Type 2 is mainly about insulin resistance, LADA is an autoimmune attack on insulin-producing cells.
Signals that point toward LADA
None of these confirm LADA on their own, but together they’re often what prompts further testing:
| Signal | More typical of Type 2 | More typical of LADA |
|---|---|---|
| Body weight at diagnosis | Often overweight | Often normal or lean |
| Family history | Type 2 diabetes | Autoimmune conditions (thyroid, celiac, etc.) |
| Response to oral medication | Sustained for years | Works at first, fades over months |
| C-peptide (insulin production) | Normal or high | Declining over time |
| GAD65 / other autoantibodies | Negative | Positive |
The tests that actually distinguish them
Two blood tests do most of the work: a GAD65 antibody test checks whether the immune system is producing antibodies against insulin-producing cells, and a C-peptide test measures how much insulin your body is still making on its own. Neither requires anything beyond a standard blood draw.
Why the distinction matters
Getting the label right changes the plan. LADA tends to progress toward insulin dependence faster than Type 2, so a doctor tracking it will typically monitor C-peptide over time and may introduce insulin earlier, before you’re in crisis, rather than waiting for oral medications to fail completely.
This page is educational, not medical advice. Testing and treatment decisions should be made with your own doctor.